Brandon Couillard
Stock Analyst at Wells Fargo
(4.30)
# 390
Out of 4,960 analysts
141
Total ratings
56.67%
Success rate
14.47%
Average return
Main Sectors:
Stocks Rated by Brandon Couillard
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CDNA CareDx | Maintains: Equal-Weight | $19 → $14 | $12.97 | +7.94% | 3 | Aug 8, 2025 | |
| MLAB Mesa Laboratories | Upgrades: Equal-Weight | $100 → $67 | $72.96 | -8.17% | 3 | Aug 8, 2025 | |
| WAT Waters | Maintains: Equal-Weight | $330 → $315 | $302.19 | +4.24% | 5 | Aug 5, 2025 | |
| BRKR Bruker | Maintains: Overweight | $60 → $50 | $35.54 | +40.69% | 5 | Aug 5, 2025 | |
| AVTR Avantor | Maintains: Overweight | $19 → $16 | $13.27 | +20.57% | 5 | Aug 4, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Equal-Weight | $245 → $265 | $303.82 | -12.78% | 12 | Aug 1, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Equal-Weight | $245 → $265 | $288.55 | -8.16% | 12 | Aug 1, 2025 | |
| RGEN Repligen | Maintains: Overweight | $180 → $175 | $124.79 | +40.24% | 2 | Jul 30, 2025 | |
| WGS GeneDx Holdings | Maintains: Equal-Weight | $78 → $95 | $128.67 | -26.16% | 4 | Jul 30, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Overweight | $570 → $565 | $499.99 | +13.00% | 6 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $210 → $205 | $211.80 | -3.21% | 3 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $59 | $57.09 | +3.35% | 1 | May 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $22 → $6 | $6.02 | -0.33% | 2 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $1,125 → $1,200 | $1,321.45 | -9.19% | 5 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $135 → $116 | $121.63 | -4.63% | 22 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $130 → $102 | $94.15 | +8.34% | 2 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $260 | $149.57 | +73.83% | 11 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $77 → $80 | $69.60 | +14.94% | 6 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $85 | $47.47 | +79.06% | 16 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $10 | $2.45 | +308.16% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $30 → $23 | $21.72 | +5.89% | 1 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $13 | $0.70 | +1,754.49% | 1 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $3.00 | - | 11 | Nov 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $2.89 | +281.28% | 2 | Oct 13, 2017 |
CareDx
Aug 8, 2025
Maintains: Equal-Weight
Price Target: $19 → $14
Current: $12.97
Upside: +7.94%
Mesa Laboratories
Aug 8, 2025
Upgrades: Equal-Weight
Price Target: $100 → $67
Current: $72.96
Upside: -8.17%
Waters
Aug 5, 2025
Maintains: Equal-Weight
Price Target: $330 → $315
Current: $302.19
Upside: +4.24%
Bruker
Aug 5, 2025
Maintains: Overweight
Price Target: $60 → $50
Current: $35.54
Upside: +40.69%
Avantor
Aug 4, 2025
Maintains: Overweight
Price Target: $19 → $16
Current: $13.27
Upside: +20.57%
Bio-Rad Laboratories
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $245 → $265
Current: $303.82
Upside: -12.78%
Bio-Rad Laboratories
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $245 → $265
Current: $288.55
Upside: -8.16%
Repligen
Jul 30, 2025
Maintains: Overweight
Price Target: $180 → $175
Current: $124.79
Upside: +40.24%
GeneDx Holdings
Jul 30, 2025
Maintains: Equal-Weight
Price Target: $78 → $95
Current: $128.67
Upside: -26.16%
Thermo Fisher Scientific
Jul 24, 2025
Maintains: Overweight
Price Target: $570 → $565
Current: $499.99
Upside: +13.00%
Jul 23, 2025
Maintains: Equal-Weight
Price Target: $210 → $205
Current: $211.80
Upside: -3.21%
May 30, 2025
Initiates: Overweight
Price Target: $59
Current: $57.09
Upside: +3.35%
May 8, 2025
Downgrades: Equal-Weight
Price Target: $22 → $6
Current: $6.02
Upside: -0.33%
May 5, 2025
Maintains: Equal-Weight
Price Target: $1,125 → $1,200
Current: $1,321.45
Upside: -9.19%
Apr 21, 2025
Maintains: Hold
Price Target: $135 → $116
Current: $121.63
Upside: -4.63%
Apr 17, 2025
Maintains: Equal-Weight
Price Target: $130 → $102
Current: $94.15
Upside: +8.34%
Jan 23, 2025
Maintains: Buy
Price Target: $285 → $260
Current: $149.57
Upside: +73.83%
Jan 23, 2025
Maintains: Hold
Price Target: $77 → $80
Current: $69.60
Upside: +14.94%
Nov 6, 2024
Maintains: Buy
Price Target: $84 → $85
Current: $47.47
Upside: +79.06%
Aug 27, 2024
Initiates: Overweight
Price Target: $10
Current: $2.45
Upside: +308.16%
Feb 9, 2024
Downgrades: Hold
Price Target: $30 → $23
Current: $21.72
Upside: +5.89%
Jul 13, 2021
Initiates: Buy
Price Target: $13
Current: $0.70
Upside: +1,754.49%
Nov 2, 2017
Downgrades: Hold
Price Target: n/a
Current: $3.00
Upside: -
Oct 13, 2017
Maintains: Buy
Price Target: $9 → $11
Current: $2.89
Upside: +281.28%